Trial Profile
Ciprofloxacin dry powder for inhalation in patients with mild-to-moderate COPD
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jul 2011
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Bacterial infections; Chronic obstructive pulmonary disease
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 23 Jul 2011 New trial record